Gmail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
  
Discussions for Wyeth View all discussions
  Wyeth and Merck May See Increased Orders for their Pneumonia Vaccines this Flu Season
Only 1 message in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
Public Health  
View profile  
 More options Oct 9, 10:40 am
From: Public Health <drplum...@gmail.com>
Date: Fri, 9 Oct 2009 07:40:24 -0700 (PDT)
Local: Fri, Oct 9 2009 10:40 am
Subject: Wyeth and Merck May See Increased Orders for their Pneumonia Vaccines this Flu Season
A significant amount of the hospitalizations and deaths associated
with an initial influenza infections are due to secondary pneumonias
that develop during the course or an individual attempting to fight
the flu. One way to protect against a common cause of secondary
pneumonia, Streptococcus pneumoniae is with a the PPSV23 a pneumonia
vaccine. It specifically protects against Sthe bacteria Streptococcus
pneumoniae. The only companies that I am aware of that market this
particular type of vaccine is the US is Wyeth and Merck. Apparantly
cases are increasing and public health officials are urging that at a
minimum high risk individuals be vaccinated.

As the article attached reads "All children under 5 should receive the
pneumococcal conjugate vaccine and people at high risk of pnemonia
between the ages of 2 and 64 and those older than 65 should receive
another pneumonia vaccine known as PPSV23, CDC officials said."
Children already get at birth so can subtract them out but all the
other high risk individuals would constiture millions of doses of
vaccine. Also, would suspect that if the cases of pneumonia increase
that there will be many more who develop pnemonia who were otherwise
considered not to be at risk, so there is the potential for greater
demand for the vaccine by others as well, not to mention global demand
in countries where they do not curretly immunize against Streptococcus
pneumoniae.
This vaccine is not cheap so would be impactful on revenue.

Streptoccocus pneumoniae is not the on culprit that can cause
secondary pneumonias.  Haemophilus influenzae, Staphylococcus aureus
and group A Streptococcus, which causes rheumatic fever and "strep
throat" can also all cause it. But, most people get vaccinated
against  Haemophilus influenzae as kids. There isn't a vaccine for
Staphlococcus aureus or Group A Strep. they're both reated with
antibiotics.

http://www.msnbc.msn.com/id/33088461/ns/health-swine_flu/

http://www.webmd.com/cold-and-flu/news/20090930/bacteria-have-role-in...

http://www.mcknights.com/CDC-recommends-pneumonia-vaccine-and-flu-vac...


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

No newer discussions   Timeline for the merger  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2009 Google